Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: Attributes and limitations of the current modalities

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3746-3751

  Jouret, François ^a,b   Lhommel, Renaud ^a   Devuyst, Olivier ^a,c   Annet, Laurence ^a   Pirson, Yves ^a   Hassoun, Ziad ^a   Kanaan, Nada ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

carbohydrate antigen 19 9; cyst infection; polycystic kidney disease; positron emission computed tomography

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; TECHNETIUM 99M; THYMIDINE;

AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CYST FLUID; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; GLOMERULUS FILTRATION RATE; HEPATITIS; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; KIDNEY CYST; KIDNEY CYST INFECTION; KIDNEY HEMORRHAGE; KIDNEY INFECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY SCINTISCANNING; LIVER CYST; LIVER CYST INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UPREGULATION;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CA-19-9 ANTIGEN; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY DISEASES; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84868584840     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs352     Document Type: Review

References (20)

1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301
2. Sallée M, Rafat C, Zahar JR et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1183-1189
3. Christophe JL, van Ypersele de Strihou C, Pirson Y. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group. Nephrol Dial Transplant 1996; 11: 1271-1276
4. Jacquet A, Pallet N, Kessler M et al. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int 2011; 24: 582-587
5. Jouret F, Lhommel R, Beguin C et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1644-1650
6. Telenti A, Torres VE, Gross JB, Jr et al. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 1990; 65: 933-942
7. Kanaan N, Goffin E, Pirson Y et al. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2010; 55: 916-922
8. Waanders E, van Keimpema L, Brouwer JT et al. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 2009; 29: 1389-1395
9. Gupta S, Seith A, Dhiman RK et al. CT of liver cysts in patients with autosomal dominant polycystic kidney disease. Acta Radiol 1999; 40: 444
10. Piccoli GB, Arena V, Consiglio V et al. Positron emission tomography in the diagnostic pathway for intracystic infection in ADPKD and 'cystic' kidneys. a case series. BMC Nephrol 2011; 12: 48
11. Migali G, Annet L, Lonneux M et al. Renal cyst infection in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2008; 23: 404-405
12. Ichioka K, Saito R, Matsui Y et al. Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease. Urology 2007; 70: 1219
13. Gilbert BR, Cerqueira MD, Eary JF et al. Indium-111 white blood cell scan for infectious complications of polycystic renal disease. J Nucl Med 1985; 26: 1283-1286
14. Sebrechts C, Biberstein M, Klein JL et al. Limitations of indium-111 leukocyte scanning in febrile renal transplant patients. AJR 1986; 146: 823-829
15. Mariani G, Bruselli L, Kuwert T et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 2010; 37: 1959-1985
16. Keidar Z, Gurman-Balbir A, Gaitini D et al. Fever of unknown origin: the role of 18F-FDG PET/CT. J NuclMed 2008; 49: 1980-1985
17. Boellaard R, O'Doherty MJ, Weber WA et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging. Eur J Nucl Med Mol Imaging 2010; 37: 181-200
18. Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HWet al. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003; 41: E18-E21
19. Bonsib SM. Renal cystic diseases and renal neoplasms: A minireview. Clin J Am Soc Nephrol 2009; 4: 1998-2007
20. Repko BM, Tulchinsky M. Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med 2008; 33: 651-653